FDA Launches Intensive Public Awareness Campaign to Combat Tobacco and Shisha Use in Accra

The Food and Drugs Authority (FDA) of Ghana has launched an intensive public awareness campaign in Accra to combat the health risks associated with tobacco and shisha use. Beginning at the authority's head office and extending to major transit hubs like the 37 Lorry Station, the initiative aims to educate drivers, commuters, and pedestrians on the severe health implications of these products. While Ghana currently maintains a relatively low tobacco prevalence rate of approximately 4%, the FDA is taking proactive steps to curb increasing exposure, particularly as shisha gains popularity in social and entertainment spaces across the capital.

Dr. Martin Kusi, the FDA’s Director of Tobacco and Substances of Abuse, emphasized that the campaign is a critical preventative measure designed to safeguard public health against long-term conditions such as cancer. He noted that while the national usage rate remains low compared to regional peers, the influence of peer pressure and social factors remains a significant threat to the youth. By targeting high-traffic areas, the FDA hopes to dispel common myths surrounding shisha—which is often erroneously perceived as a safer alternative to traditional cigarettes—and provide citizens with the factual information necessary to make informed health choices.

Beyond public education, the FDA is implementing a multi-pronged strategy that includes close collaboration with the hospitality and entertainment sectors. Officials are working with hotel and lounge operators to ensure strict compliance with existing tobacco regulations and to monitor social venues where shisha is frequently consumed. Additionally, the authority is partnering with national security agencies to address the unauthorized entry of tobacco products into the country. By tightening border surveillance and identifying illegal routes, the FDA seeks to limit the accessibility and availability of unregulated tobacco and shisha products to the general public.

Although there is currently no outright ban on tobacco in Ghana, the FDA’s intensified efforts signal a robust commitment to regulating its use and protecting vulnerable populations from second-hand smoke and addiction. The authority plans to continue its educational initiatives and stakeholder engagements to foster a culture of compliance with health regulations. As the campaign moves forward, the focus will remain on reducing the social appeal of tobacco and ensuring that the country's low prevalence rate does not trend upward due to modern consumption trends like flavored shisha.